RecruitingNot ApplicableNCT07724587

The Effectiveness and Safety of Combined Research on Uremic Sarcopenia

A Study on the Clinical Efficacy and Safety Evaluation of Mindfulness Meditation During Dialysis Combined With Pre-Dialysis Progressive Resistance Training for Hemodialysis Patients With Sarcopenia


Sponsor

Ningbo Medical Center Lihuili Hospital

Enrollment

76 participants

Start Date

Sep 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Objective: To investigate the clinical efficacy and safety of mindfulness meditation during dialysis combined with pre-dialysis progressive resistance training (PRT) for sarcopenia in patients undergoing maintenance hemodialysis (MHD). Methods: In the randomized controlled trial, 76 MHD patients with sarcopenia were divided into three groups: control group (CG), sports group (SG), and intervention group (IG). All groups received standard dialysis, health education, and dietary guidance. The SG received pre-dialysis PRT, while the IG added mindfulness meditation during dialysis. Efficacy and safety were evaluated at baseline and after 12 weeks. Ultrasound assessments of muscle mass were conducted at baseline, week 4, week 8, and week 12.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Received mindfulness meditation training during dialysis in addition to exercise therapy. for people with sarcopenia. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALReceived mindfulness meditation training during dialysis in addition to exercise therapy.

The SG received pre-dialysis progressive resistance training (PRT), while the IG added mindfulness meditation during dialysis.


Locations(1)

Yongyao Wu

Ningbo, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07724587


Related Trials